843 related articles for article (PubMed ID: 17278119)
1. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
3. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
[TBL] [Abstract][Full Text] [Related]
5. The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma.
Shimizu Y; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Miyazaki M
Hepatogastroenterology; 2008; 55(82-83):699-703. PubMed ID: 18613437
[TBL] [Abstract][Full Text] [Related]
6. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
[TBL] [Abstract][Full Text] [Related]
7. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis of intrahepatic cholangiocarcinoma after resection.
Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
[TBL] [Abstract][Full Text] [Related]
10. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for radical resection of middle and distal bile duct cancer.
Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
[TBL] [Abstract][Full Text] [Related]
12. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
[TBL] [Abstract][Full Text] [Related]
13. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.
Uenishi T; Kubo S; Yamazaki O; Yamada T; Sasaki Y; Nagano H; Monden M
J Hepatobiliary Pancreat Surg; 2008; 15(4):417-22. PubMed ID: 18670844
[TBL] [Abstract][Full Text] [Related]
14. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Kinoshita H
Br J Surg; 2001 Jul; 88(7):969-74. PubMed ID: 11442529
[TBL] [Abstract][Full Text] [Related]
18. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
[TBL] [Abstract][Full Text] [Related]
20. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
